At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Ferric carboxymaltose +1 moredrug
Likely dose
Ferric carboxymaltose 15 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Endogenous Iron Status and Intravenous Iron on Human Skeletal Muscle Metabolism at Rest and During Exercise
In Brief
A clinical study evaluating Ferric carboxymaltose and Sodium chloride (placebo) for Iron Deficiency. Completed, enrolled 29 participants across 1 site.
Detailed Summary
Iron deficiency is common in cardiorespiratory diseases and appears to contribute to a worse outcome. This human physiology study will examine the extent to which human skeletal muscle metabolism and exercise physiology are impaired by iron deficiency.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIron Deficiency
CountriesUnited Kingdom
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedDec 2014
Primary CompletionDec 2015
Study CompletionJan 2016
TodayJul 2026
First PostedDec 4, 2014
Enrollment StartOct 1, 2014
Primary CompletionDec 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.6 years ago
Interventions
Ferric carboxymaltosedrug
Infusion of 15 mg/kg (up to maximum 1000 mg) ferric carboxymaltose in 250 mL 0.9% sodium chloride
Sodium chloride (placebo)drug
Infusion of 250 mL 0.9% sodium chloride